ライフサイエンスコーパス: breast reconstruction

1 g of the abdomen before undergoing DIEP flap breast reconstruction.

2 or ethnicity, appear to influence the use of breast reconstruction.

3 e number of radiated patients presenting for breast reconstruction.

4 economic characteristics are associated with breast reconstruction.

5 tralateral prophylactic mastectomy (CPM) and breast reconstruction.

6 ong patients undergoing autologous free flap breast reconstruction.

7 orted outcomes (PROs) in patients undergoing breast reconstruction.

8 and sexual well-being in patients undergoing breast reconstruction.

9 st cancer and underwent autologous free flap breast reconstruction.

10 luate temporal trends in receipt of PMRT and breast reconstruction.

11 making is needed to support decisions about breast reconstruction.

12 ursuing mastectomy, which may be followed by breast reconstruction.

13 autologous (AT), and direct-to-implant (DI) breast reconstruction.

14 e tissue donated by healthy women undergoing breast reconstruction.

15 ssess the quality of patient decisions about breast reconstruction.

16 mastectomy for breast cancer do not undergo breast reconstruction.

17 rgoing mastectomy with and without immediate breast reconstruction.

18 ergoing mastectomy with or without immediate breast reconstruction.

19 tion and in those undergoing tissue expander breast reconstruction.

20 ads to decreased flap survival in autologous breast reconstruction.

21 period, of which 9315 (19.2%) had immediate breast reconstruction.

22 to combine this new method with the standard breast reconstruction.

23 atients after immediate unilateral DIEP flap breast reconstruction.

24 ence cost variation for autologous free flap breast reconstruction.

25 ticenter prospective longitudinal studies in breast reconstruction.

26 n that minority women have limited access to breast reconstruction.

27 east cancers in autogenous myocutaneous flap breast reconstructions.

28 Although immediate breast reconstruction after mastectomy has become routin

29 luded women 18 years or older presenting for breast reconstruction after mastectomy with 2 years or m

30 outcome measures include temporal trends in breast reconstruction and bilateral mastectomy for unila

31 ve recovery between the 2 groups (lymphedema breast reconstruction and breast reconstruction) were co

32 d with simultaneous bilateral TRAM free flap breast reconstruction and describe refinements in its su

33 n the patients undergoing mastectomy without breast reconstruction and in those undergoing tissue exp

34 h validated scales to assess knowledge about breast reconstruction and involvement in decision making

35 ing clinician comfort with irradiating a new breast reconstruction and may have cosmetic and quality-

36 As the use of breast reconstruction and postmastectomy radiotherapy (P

37 view of available literature on the topic of breast reconstruction and radiation is presented.

38 st cancer patients to enhance the quality of breast reconstruction and the related risks.

39 BCS-eligible patients undergoing mastectomy, breast reconstruction, and bilateral mastectomy.

40 ate their natural breast, mastectomy site or breast reconstruction, and external silicone models.

41 efore and after delayed unilateral DIEP flap breast reconstruction, and on four patients after immedi

42 s influencing the decision-making process in breast reconstruction are analyzed.

43 edures, including unplanned revisions, after breast reconstruction are common and vary by reconstruct

44 al morbidity, especially when mastectomy and breast reconstruction are done for widespread low-grade

45 on morbidity after mastectomy with immediate breast reconstruction are limited.

46 New trends of immediate breast reconstruction are presented.

47 urpose The goals of immediate postmastectomy breast reconstruction are to minimize deformity and opti

48 , 2015, among ambulatory patients undergoing breast reconstruction at an academic ambulatory care hos

49 Breast reconstruction at any time after mastectomy and p

50 bstracts identified in the field of HRQoL in breast reconstruction between 1978 and 2009.

51 kin-sparing mastectomy facilitates immediate breast reconstruction by reducing remedial surgery on th

52 Patients undergoing ambulatory breast reconstruction can use follow-up care via a mobil

53 risk of lymphedema associated with immediate breast reconstruction compared to mastectomy alone.

54 nts who received a lipofilling procedure for breast reconstruction compared with controls.

55 risk for breast cancer if autogenous tissue breast reconstruction could be performed with reasonable

56 Complication risks after immediate breast reconstruction differ by approach.

57 e complications related to flap survival for breast reconstruction, especially in obese subjects.

58 Overall, 42% of patients had breast reconstruction following mastectomy.

59 rafting has proven to be a useful adjunct to breast reconstruction for the treatment of contour irreg

60 Women undergoing mastectomy and breast reconstruction for unilateral breast cancer were

61 omen who underwent mastectomy with immediate breast reconstruction from 2008 to 2009.

62 ergoing mastectomy with or without immediate breast reconstruction from January 1, 2005, through Dece

63 t had no significant effect in the immediate breast reconstruction group (OR, 0.98; 95% CI, 0.79-1.23

64 ation time was 426 minutes in the lymphedema breast reconstruction group and 391 minutes in the breas

65 reconstruction group and 391 minutes in the breast reconstruction group.

66 Although breast reconstruction has been shown to confer significa

67 Breast reconstruction has increased over time, but it ha

68 al approach to integrating radiotherapy with breast reconstruction has provoked intense controversy i

69 Breast reconstruction has the potential to improve a per

70 tion of these technologies in the setting of breast reconstruction have arisen.

71 Most studies of complications after breast reconstruction have been conducted at centers of

72 elopments in oncoplastic surgery and partial-breast reconstruction have improved cosmetic outcomes af

73 30 years, significant technical advances in breast reconstruction have increased performance of this

74 Variations in who undergoes breast reconstruction have led to questions about the qu

75 Immediate breast reconstruction (IBR) after mastectomy for cancer

76 y sensitive to measure changes consequent to breast reconstruction (ie, effect on body image or psych

77 Few studies have examined whether breast reconstruction impacts development of lymphedema.

78 by this pattern may be a mechanism by which breast reconstruction improves self-perception, and thus

79 2010, we performed free lower abdominal flap breast reconstruction in 87 patients.

80 p inferior epigastric perforator (DIEP) flap breast reconstruction in an attempt to better understand

81 e complications after implant and autologous breast reconstruction in patients undergoing unilateral

82 t WAT-derived cells used in lipotransfer for breast reconstruction in patients with breast cancer.

83 rted outcomes after unilateral and bilateral breast reconstruction in patients with unilateral breast

84 the optimal integration of radiotherapy and breast reconstruction in the management of breast cancer

85 Breast reconstruction increased across all cohorts.

86 In women undergoing mastectomy, rates of breast reconstruction increased from 11.6% in 1998 to 36

87 Breast reconstruction is an important treatment option f

88 Immediate breast reconstruction is associated with a statistically

89 Breast reconstruction is associated with high levels of

90 regarding the incidence of SSI in immediate breast reconstruction is highly variable and series depe

91 Immediate breast reconstruction is increasingly performed at the t

92 whom RT could be avoided or mastectomy with breast reconstruction is indicated.

93 hospital variation for autologous free flap breast reconstruction is unknown.

94 vasive carcinoma underwent SSM and immediate breast reconstruction (June 1986 to December 1997).

95 ion during autologous fat transplantation in breast reconstruction, little is known about its mechani

96 ys in TTC included low socioeconomic status, breast reconstruction, nonprivate insurance, and Hispani

97 y in the group undergoing mastectomy without breast reconstruction (odds ratio [OR], 0.80; 95% CI, 0.

98 (OR, 0.59; 95% CI, 0.48-0.72), any immediate breast reconstruction (OR, 0.57; 95% CI, 0.37-0.88), and

99 0.59; 95% CI, 0.49-0.71), mastectomy without breast reconstruction (OR, 0.59; 95% CI, 0.48-0.72), any

100 y in the group undergoing mastectomy without breast reconstruction (OR, 0.61; 95% CI, 0.51-0.73) and

101 support the need for additional longitudinal breast reconstruction outcome studies.

102 ients were recruited as part of the Michigan Breast Reconstruction Outcome Study, a 12 center, 23 sur

103 approach may be preferable to mastecomy and breast reconstruction, particularly when postmastectomy

104 antial healthcare charges to the care of the breast reconstruction patient.

105 more attention has focused on postmastectomy breast reconstruction (PBR).

106 The immediate breast reconstruction population included 19,258 patient

107 all radiotherapy in the context of immediate breast reconstruction present special challenges.

108 sks associated with the use of WAT cells for breast reconstructions should be better investigated ret

109 Breast reconstruction studies increasingly aim to assess

110 e lowest after expander and highest after AT breast reconstruction (TE = 6.5% [reference] vs AT = 13.

111 de a safe oncologic procedure with immediate breast reconstruction that could technically be applied

112 The mean cost for autologous free flap breast reconstruction was $22677 (interquartile range, $

113 nt 240 simultaneous bilateral TRAM free flap breast reconstructions was developed.

114 of 34 papers that included HRQL outcomes in breast reconstruction were identified and reviewed in de

115 groups (lymphedema breast reconstruction and breast reconstruction) were compared.

116 ns have led to an increased use of immediate breast reconstruction, which has resulted in uncertainty

117 ess acculturated Latinas, had low receipt of breast reconstruction, which may be related to limited i

118 regarding breast cancer patients' access to breast reconstruction, which provides important psychoso

119 66,593 (77.6%) underwent mastectomy without breast reconstruction, with 2876 (4.3%) receiving NC; 78

120 g stable in other cohorts and (2) receipt of breast reconstruction would decrease in these women whil